Skip to main content

Table 5 Multivariate model for the relative risk of parasite clearance

From: Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial

Variable

Hazard ratio

95% CI

P

Treatment with AS/SP vs. SP

1.8

1.4 – 2.3

<0.001

Log10 parasite density (per μl) blood)

0.8

0.7 – 0.8

<0.001

Catuane (compared to other sites)

1.8

1.3 – 2.5

<0.001

  1. SP: sulphadoxine-pyrimethamine
  2. AS/SP: artesunate/sulphadoxine-pyrimethamine
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us